| Code | 94921 | ||||||||||
| MA number | 52/0186/92-CS | ||||||||||
| Product Form: | sir 1x100 ml/300 mg | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | National | ||||||||||
| Therapeutic Class: | 52 - EXPECTORANTIA, MUCOLYTICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 60 | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product not subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 25.03.1992 |
| Pediatric posology: | Yes |
| Pediatric contraindication: | Yes |
| PIL: |
PIL_Ambrobene 15mg_5ml sir_05_2022.pdf
|
| PIL: |
PIL_Ambrobene 15mg_5ml sir_čas použiteľnosti po prvom otvorení_01/2024.pdf
|
| SPC: |
SPC_Ambrobene 15mg_5ml sir_05/2022.pdf
|
| SPC: |
SPC_Ambrobene 15mg_5ml sir_čas použiteľnosti po prvom otvorení_03/2024.pdf
|
| Safety feature | No |
| Data update: | 25.01.2019 |
